1. Home
  2. Analysis
  3. Gammagard
  4. Famciclovir

Gammagard and Famciclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gammagard (immune globulin) and Famciclovir (famciclovir). Common drug interactions include bronchitis among females.

The phase IV clinical study analyzes what interactions people have when they take Gammagard and Famciclovir. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Gammagard?

Gammagard has active ingredients of immune globulin. eHealthMe is studying from 8,948 Gammagard users. Check the latest studies of Gammagard.

What is Famciclovir?

Famciclovir has active ingredients of famciclovir. It is often used in herpes zoster. eHealthMe is studying from 3,389 Famciclovir users. Check the latest studies of Famciclovir.

On Jul, 19, 2026

28 people who take Gammagard and Famciclovir together, and have interactions are studied.

Gammagard and Famciclovir drug interactions.

What are the common drug interactions of Gammagard and Famciclovir, by gender? *:

female:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Urinary tract infection
  3. Pain
  4. Vomiting
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Burning sensation
  8. Neck pain
  9. Sinusitis (inflammation of sinus)
  10. Fall

male:

n/a

What are the common drug interactions of Gammagard and Famciclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Drug ineffective
  3. Arthropathy
  4. Blood pressure increased
  5. Concussion (short loss of normal brain function in response to a head injury)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Gait disturbance
  8. Herpes virus infection
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Ill-defined disorder

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 11 people, 39.29%
  2. Multiple Myeloma (cancer of the plasma cells): 8 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Gammagard and Famciclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gammagard and Famciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gammagard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Famciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gammagard and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Famciclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on immune globulin and famciclovir (the active ingredients of Gammagard and Famciclovir, respectively), and Gammagard and Famciclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.